"Everything Falls On My Shoulders, Can't Do It Alone": Adar Poonawalla On Vaccine Pressure | Read

  • 0:46
  • Published On: May 01, 2021
Cinema View
Embed
Serum Institute of India CEO Adar Poonawalla on Saturday spoke out about the pressures he was under over the production of COVID-19 vaccines to meet the ever-increasing demand in India as the country battles through a devastating second wave of the coronavirus pandemic. In his first comments since he was provided with 'Y'' category security by the Indian government earlier this week, Mr Poonawalla told 'The Times'' in an interview about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield - the Oxford/AstraZeneca COVID-19 vaccine that the Serum Institute is producing in India.

Related Videos

AstraZeneca Initiates A Global Withdrawal Of Its Covid-19 Vaccine
May 08, 2024 2:12
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
May 08, 2024 2:54
AstraZeneca Withdraws Covid Vaccine, Cites Commercial Reasons: Report
May 08, 2024 0:45
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
May 06, 2024 1:53
"Doctors Were Clueless, Didn't Suspect Vaccine": Man Whose Daughter Died Due To Vaccine Side-Effect
May 05, 2024 4:27
"Information Is Not New, No Need To Worry": Ex WHO Chief Scientist On Covishield Concern
May 05, 2024 4:56
"All Drugs, Vaccines Come With Some Side-Effects": Top Expert
May 05, 2024 1:07
"No Vaccine Is 100% Effective Or 100% Safe": Expert On Covishield Concern
May 05, 2024 2:18
Ex WHO Chief Scientist, Top Doctors Answer AstraZeneca Vaccine Concerns
May 05, 2024 26:44
AstraZeneca Covid 19 Vaccine Side Effects | What Is TTS, A Rare Condition Caused By Covishield
May 01, 2024 4:03
Covishield Vaccine से हो सकता है Heart Attack! AstraZeneca ने कबूली बात
May 01, 2024 3:36
Astrazeneca's Big U-Turn, Admits Rare Blood Clot Risk
April 30, 2024 2:21
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination